This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Manenti, S. Articles by Darbon, J.-M. Search for Related Content PubMed PubMed Citation Articles by Manenti, S. Articles by Darbon, J.-M.

Overexpression of the Myristoylated Alanine-rich C Kinase Substrate in Human Choroidal Melanoma Cells Affects Cell Proliferation¹

Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Fédératif de Recherche 30, Toulouse Cedex, France

Reduced expression of the myristoylated alanine-rich C kinase substrate (MARCKS) has been described in various cell lines after oncogenic or chemical transformation, leading to the question of whether this protein may be involved in cell proliferation. Here we compare the expression of MARCKS in human tumor-derived choroidal melanoma cells (OCM-1) and in primary cultures of normal choroidal melanocytes. We found an important down-regulation of the protein in the melanoma cell line. Stable transfection of these cells with the cDNA coding for MARCKS led to the selection of several clones expressing variable levels of the protein. Proliferation experiments performed with four of these clones revealed that cell growth was reduced by 35–40% when compared with control cells. Upon serum starvation, cell proliferation was almost abolished when the expression level of MARCKS was high, whereas it was only partially reduced in the controls. MARCKS overexpression induced a higher percentage of cells in the G₀–G₁ phase of the cell cycle upon serum starvation, as well as the inhibition of colony formation in soft agar. Finally, the expression of the CDK inhibitor p27 was increased in the cells presenting a high level of MARCKS protein. Altogether, these data suggest that the expression of this protein kinase C substrate affects the proliferation and partially reverts the transformed phenotype of the OCM-1 cells.

¹ This work was supported by the Institut National de la Santé et de la Recherche Médicale, by the Ligue Nationale contre le Cancer, and by the Région Midi-Pyrénnées.

² To whom requests for reprints should be addressed, at INSERM CJF 95-10, CHU Purpan, Pavillon Rayer, 31059 Toulouse Cedex, France. Phone: (33) 561 77 25 00; Fax: (33) 561 77 25 68; E-mail: manenti@purpan.inserm.fr.

Received 8/25/97. Accepted 1/22/98.

This article has been cited by other articles:

				F. Uno, J. Sasaki, M. Nishizaki, G. Carboni, K. Xu, E. N. Atkinson, M. Kondo, J. D. Minna, J. A. Roth, and L. Ji Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells Cancer Res., May 1, 2004; 64(9): 2969 - 2976. [Abstract] [Full Text] [PDF]

				Z.-y. Huang, Y. Wu, S. P. Burke, and D. H. Gutmann The 43,000 Growth-associated Protein Functions as a Negative Growth Regulator in Glioma Cancer Res., June 1, 2003; 63(11): 2933 - 2939. [Abstract] [Full Text] [PDF]

				Y. Zhao, B. S. Neltner, and H. W. Davis Role of MARCKS in regulating endothelial cell proliferation Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1611 - C1620. [Abstract] [Full Text] [PDF]